1-(2,6-Dimethylphenyl)-4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazine

Catalog No. :
ACIECP230
CAS No. :
338962-60-0
Molecular Formula :
C18H19F3N6
Molecular Weight :
376.39

IUPAC Name:6-(4-(2,6-dimethylphenyl)piperazin-1-yl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine

1-(2,6-Dimethylphenyl)-4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2,6-Dimethylphenyl)-4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazine
IUPAC Name6-(4-(2,6-dimethylphenyl)piperazin-1-yl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine
MDL No.MFCD01315950
Molecular FormulaC18H19F3N6
Molecular Weight376.39
SMILESFC(C1=NN=C2C=CC(N3CCN(C4=C(C)C=CC=C4C)CC3)=NN21)(F)F
InChI KeyFZCLCZFKPUJXFM-UHFFFAOYSA-N
Synonym6-[4-(2,6-DIMETHYLPHENYL)PIPERAZINO]-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE;1-(2,6-dimethylphenyl)-4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazine;1,2,4-Triazolo[4,3-b]pyridazine, 6-[4-(2,6-dimethylphenyl)-1-piperazinyl]-3-(trifluoromethyl)-
CAS No.338962-60-0

Synthetic Route by SureRoute

1. ACIECP230 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBCFS068 route compound structure diagram
    ACBCFS06840971-95-7 In Stock
  4. Then
  5. ACIECP230 route product structure diagram
    ACIECP230338962-60-0
Inquiry

2. ACIECP230 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIECP230 route product structure diagram
    ACIECP230338962-60-0
Inquiry

Comments (0)